Seroresponses to virus-like particles of human papillomavirus types 16, 18, 31, 33, and 45 in San people of Southern Africa

Journal of Medical Virology

Volumn 60, Issue 3, 2000, Pages 331-336

  Marais, Dianne ^a   Rose, Robert C ^b   Lane, Christopher ^b   Aspinall, Sanet ^c   Bos, Pieter ^c   Williamson, Anna Lise ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^c SEFAKO MAKGATHO HEALTH SCIENCES UNIVERSITY   (South Africa)

Author keywords

Antibodies; HPV; San (bushmen); Serology; VLP

Indexed keywords

VIRUS ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; SEROPREVALENCE; SOUTH AFRICA; VIRUS PARTICLE; WART VIRUS;

EID: 0033978508     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(200003)60:3<331::AID-JMV12>3.0.CO;2-A     Document Type: Article

References (37)

1. af Geijersstam V, Eklund C, Wang Z, Sapp M, Schiller JT, Dillner J, Dillner L. 1999. A survey of seroprevalence of human papillomavirus types 16, 18 and 33 among children. Int J Cancer 80:489-493.
2. Bloch B, Homer L, Orford HJL, Roberts MA. 1988. High-risk factors for cervical cancer. An epidemiological study in SWA/Namibia. S Afr Med J 74:284-289.
3. Bosch FX, Manos M, Muñoz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R, Shah KV. 1995. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J Nat Cancer Inst 87:796-802.
4. Cason C, Kaye JN, Jewers RJ, Kambo PK, Bible JM, Kell B, Shergill B, Parkarian K, Raju S, Best JM. 1995. Perinatal infection and persistence of human papillomavirus types 16 and 18 in infants. J Med Virol 47:209-218.
5. Chabaud M, Le Cann P, Mayelo V, Leboulleux D, Diallo AS, Enogat N, Afoutou JM, Anthonioz P, Coll-Seck AM, Coursaget P. 1996. Detection by PCR of human papillomavirus genotypes in cervical lesions of Senegalese women. J Med Virol 49:259-263.
6. Chua K-L, Wiklund F, Lenner P, Ångström T, Hallmans G, Bergman F, Sapp M, Schiller J, Wadel G, Hjerpe A, Dillner J. 1996. A prospective study on the risk of cervical intraepithelial neoplasia among healthy subjects with serum antibodies to HPV compared with HPV DNA in cervical smears. Int J Cancer 68:54-59.
7. Cooper K, Herrington CS, Graham AK, Evans MF, McGee JO'D. 1991a. In situ human papillomavirus (HPV) genotyping of cervical intraepithelial neoplasia in South African and British patients: evidence for putative HPV integration in vivo. J Clin Pathol 44: 400-405.
8. Cooper K, Herrington CS, Graham AK, Evans MF, McGee JO'D. 1991b. In situ evidence for HPV 16, 18, 33 integration in cervical cell cancer in Britain and South Africa. J Clin Pathol 44:406-409.
9. Deacon HJ. 1992. Southern Africa and modern human origins. Philos Trans R Soc Lond Ser B 337(280):177-183.
10. Dillner J, Wiklund F, Lenner P, Eklund C, Fredriksson-Shanazarian V, Schiller JT, Hibma M, Hallmans G, Stendahl U. 1995. Antibodies against linear and conformational epitopes of human papillomavirus type 16 that independently associate with incident cancer. Int J Cancer 60:377-382.
11. Dillner J, Kallings I, Brihmer C, Sikström B, Koskela P, Lehtinen M, Schiller JT, Sapp M, Mårdh PA. 1996. Seropositivities to human papillomavirus types 16, 18, or 33 capsids and to Chlamydia trachomatis are markers of sexual behavior. J Infect Dis 173:1394-1398.
12. du Toit ED, Taljaard DJ, Marshall J, Ritchie C, Outshoorn M. 1990. The HLA genetic constitution of the bushmen (San). Hum Immunol 28:406-415.
13. Gaobepe M, Aspinall S, Bos P. 1995. Hepatitis B viral markers in bushmen at Schmidtsdrift, South Africa: baseline studies for immunisation. East Afr Med J 72:421-423.
14. Hamšiková E, Šmahel M, Sapp M, Muñoz N, Bosch FX, Shah KV, Vonka V. 1997. Correlation between the presence of anti HPV33 VLP antibodies and HPV DNA in cervical neoplasia patients. Arch Virol 142:413-416.
15. Hamšiková E, Ludviková V, Šmahel M, Sapp M, Vonka V. 1998. Prevalence of antibodies to human papillomaviruses in the general population of the Czech Republic. Int J Cancer 77:689-694.
16. International Agency for Research on Cancer (IARC/WHO). 1999. The current status of the development of prophylactic vaccines against human papillomavirus infection. Report of a technical meeting, Geneva, February 16-18.
17. Kirnbauer R, Hubbert NL, Wheeler CM, Becker TM, Lowy DR, Schiller JT. 1994. A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16. J Natl Cancer Inst 86:494-499.
18. Marais DJ, Rose RC, Williamson A-L. 1997. Age distribution of antibodies to human papillomavirus in children, women with cervical intraepithelial neoplasia and blood donors from South Africa. J Med Virol 51:126-131.
19. Matsumoto K, Yoshikawa H, Taketani Y, Yoshiike K, Kande T. 1997. Antibodies to human papillomavirus 16, 18, 58, and 6b major capsid proteins among Japanese females. Jpn J Cancer Res 88:369-375.
20. NIH Consens Statement. 1996. Cervical cancer. NIH Consens Statement 14:1-38.
21. Nonnenmacher B, Hubbert N, Kirnbauer R, Shah KV, Muñoz N, Bosch FX, de Sanjosé S, Viscidi R, Lowy DR, Schiller J. 1995. Serological response to human papillomavirus type 16 (HPV-16) virus-like particles in HPV-16 DNA-positive invasive cancer and cervical intraepithelial neoplasia grade III patients and controls from Columbia and Spain. J Infect Dis 172:19-24.
22. Nonnenmacher B, Kruger Kjaer S, Svare EI, Scott JD, Hubbert N, Van Den Brull AJC, Kirnbauer R, Walboomers JMM, Lowy DR, Schiller J. 1996. Seroreactivity to HPV-16 virus-like particles as markers for cervical cancer in high risk areas. Int J Cancer 68: 704-709.
23. Puranen MH, Yliskoski MH, Saarikoski SV, Syrjänen KJ, Syrjänen SM. 1997. Exposure of an infant to cervical human papillomavirus infection of the mother is common. Am J Obstet Gynecol 176: 1039-1045.
24. Ramesar JE, Dehaek CMC, Soeters R, Williamson A-L. 1996. The detection of human papillomavirus in normal scrapes from Cape Town, South Africa. S Afr Med J 86:1402-1405.
25. Roden RB, Hubbert NL, Kirnbauer R, Christensen ND, Lowy DR, Schiller JT. 1996. Assessment of the serological relatedness of genital human papillomaviruses by hemagglutination inhibition. J Virol 70:3298-3301.
26. Rose RC, Bonnez W, Reichman RC, Garcea RL. 1993. Expression of human papillomavirus type 11 L1 protein in insect cells: in vivo and in vitro assembly of virus-like particles. J Virol 67:1936-1944.
27. Rose RC, Bonnez W, Da Rin C, McCance J, Reichman RC. 1994. Serological differentiation of human papillomavirus types 11, 16, and 18 using recombinant virus-like particles. J Gen Virol 75: 2445-2449.
28. Schiffman MH, Brinton LA. 1995. The epidemiology of cervical carcinogenesis. Cancer 76:1888-1901.
29. Schmauz R, Okong P, de Villiers EM, Dennin R, Lwanga SK, Owor R. 1989. Multiple infections in cases of cervical cancer from a high incidence area in tropical Africa. Int J Cancer 43:805-809.
30. Strickler HD, Kirk GD, Figueroa JP, Ward E, Braithwaite AR, Escoffery C, Drummond J, Goebal B, Waters D, McClimens R, Manns A. 1999. HPV 16 antibody prevalence in Jamaica and the United States reflects differences in cervical cancer rates. Int J Cancer 80:339-344.
31. Tachezy R, Hamšiková E, Hájek T, Mikyšková I, Šmahel M, Van Ranst M, Kaňka J, Havránková A, Rob L, Guttner V, Slavík V, Anton M, Kratochvíl B, Kotršová L, Vonka V. 1999. Human papillomavirus genotype spectrum in Czech women: correlation of HPV DNA presence with antibodies against HPV-16, 18, and 33 virus-like particles. J Med Virol 58:378-386.
32. ter Meulen J, Eberhardt HC, Luande J, Mgaya HN, Change-Claude J, Mtiro H, Mhina M, Kashaija P, Ockert S, Yu X, Meinhardt G, Gissmann L, Pawlita M. 1992. Human papillomavirus (HPV) infection, HIV infection and cervical cancer in Tanzania, East Africa. Int J Cancer 51:515-521.
33. Wang Z, Konya J, Avall-Ludkvist E, Sapp M, Dillner J, Dillner L. 1997. Human papillomavirus antibody responses among patients with incident cervical carcinoma. J Med Virol 52:436-440.
34. Wideroff L, Schiffman MH, Nonnenmacher B, Hubbert N, Kirnbauer R, Greer CE, Lowy D, Lorincz, Manos MM, Glass AG, Scott DR, Sherman ME, Kurman RJ, Buckland J, Tarone RE, Schiller J. 1995. Evaluation of seroreactivity to human papillomavirus type 16 virus-like particles in an incident case-control study of cervical neoplasia. J Infect Dis 172:1425-1430.
35. Wikström A, van Dornum JJ, Quint GV, Schiller JT, Dillner J. 1995. Identification of human papillomavirus seroconversions. J Gen Virol 76:529-539.
36. Williamson A-L, Dehaeck MC, Soeters R. 1989. Typing of human papillomaviruses in cervical intraepithelial neoplasia grade 3 biopsies from Cape Town. J Med Virol 28:146-149.
37. Williamson A-L, Brink NS, Dehaeck MC, Ovens S, Soeters R, Rybicki EP. 1994. Typing of human papillomaviruses in cervical carcinoma biopsies from Cape Town. J Med Virol 43:231-237.